Paroxetine and Drug exposure during pregnancy - a phase IV clinical study of FDA data

Summary:

Drug exposure during pregnancy is found among people who take Paroxetine, especially for people who are 30-39 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Paroxetine and have Drug exposure during pregnancy. It is created by eHealthMe based on reports of 56,969 people who have side effects when taking Paroxetine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jun, 01, 2023

56,969 people reported to have side effects when taking Paroxetine.
Among them, 1,552 people (2.72%) have Drug exposure during pregnancy.

What is Paroxetine?

Paroxetine has active ingredients of paroxetine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 58,198 Paroxetine users for its effectiveness, alternative drugs and more.

What is Drug exposure during pregnancy?

Drug exposure during pregnancy is found to be associated with 1,778 drugs and 1,467 conditions by eHealthMe.

Number of Paroxetine and Drug exposure during pregnancy reports submitted per year:

Could Paroxetine cause Drug exposure during pregnancy?

* Approximation only. Some reports may have incomplete information.

Do you take Paroxetine and have Drug exposure during pregnancy?

Check whether Drug exposure during pregnancy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .

Related studies

How severe was Drug exposure during pregnancy and when was it recovered:

Drug exposure during pregnancy in Paroxetine

Expand to all the drugs that have ingredients of paroxetine hydrochloride:

Drug exposure during pregnancy and drugs with ingredients of paroxetine hydrochloride (9,154 reports)

Alternative drugs to, pros and cons of Paroxetine:

Paroxetine (58,198 reports)

Common Paroxetine side effects:

Stress and anxiety: 4,007 reports
Fatigue (feeling of tiredness): 3,970 reports
Dizziness: 3,506 reports
Drug ineffective: 3,397 reports
Depression: 3,150 reports
Headache (pain in head): 3,042 reports
Diarrhea: 3,038 reports
Suicidal ideation: 2,774 reports

Browse all side effects of Paroxetine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drug exposure during pregnancy treatments and more:

Drug exposure during pregnancy (58,630 reports)

COVID vaccines that are related to Drug exposure during pregnancy:

Common drugs associated with Drug exposure during pregnancy:

All the drugs that are associated with Drug exposure during pregnancy:

Drug exposure during pregnancy (1,778 drugs)

Common conditions associated with Drug exposure during pregnancy:

All the conditions that are associated with Drug exposure during pregnancy:

Drug exposure during pregnancy (1,467 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paroxetine hydrochloride (the active ingredients of Paroxetine) and Paroxetine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.